Orchestra BioMed Files Investor Presentation (8-K)

What Happened

• Orchestra BioMed Holdings, Inc. (OBIO) filed a Current Report on Form 8‑K on September 8, 2026 under Item 7.01 (Regulation FD Disclosure) to attach an investor slide presentation. The presentation is included as Exhibit 99.1 and is stated to be used at investor and industry conferences and presentations. The exhibit is incorporated into the filing solely for the purposes of Item 7.01.

Key Details

• Filing date: September 8, 2026 (Form 8‑K).
• Exhibit included: Exhibit 99.1 — Investor Presentation used at conferences.
• Regulatory context: Reported under Item 7.01 (Regulation FD Disclosure).
• No other material actions in this filing: The 8‑K does not report earnings, executive changes, mergers, or bankruptcy (only the presentation exhibit and cover page data are listed).

Why It Matters

• For investors, this filing makes the company’s current presentation materials public and ensures equal access under Regulation FD. Review the attached Exhibit 99.1 for the company’s latest messaging on business strategy, pipeline, or performance metrics. This is a routine disclosure of presentation materials and not an earnings report or an announcement of corporate changes.